Phytochemical and biological activity study on Pseuduvaria Rugosa (annonaceae) / Hairin Taha by Hairin, Taha
1 
 
 
CHAPTER ONE 
                                        INTRODUCTION 
 
1.1  General     
Plants have variety of chemical constituents called ‘phytochemicals’ with protective and 
disease preventive properties. The term ‘phytochemicals’ are chemical substances that 
produced naturally in plants that demonstrate various biological activities that include 
antioxidant, antibacterial, antifungal, anti-inflammatory, anti malarial and anticancer 
activities [1]. 
These phytochemicals   include  isoflavones, flavanoids and lycopene which are 
clinically proven to be of valuable therapeutic importance which may help in the 
treatment of many diseases such as cancer, cardiovascular disease, degenerative diseases 
and HIV infection [2-3]. Vegetables, fruits, herbs and seeds are some of the plants that 
contain phytochemicals that are rich in phenolic compounds such as  flavanoids,  
phenolic acids,  anthraquinones  and  coumarins [4]. 
Research in natural products seemed to be unbounded and limitless, and recently the 
interest in this area of study has revived and increased considerably especially with the 
latest development of technology in separation methods, spectroscopic techniques and 
advanced bioassays. Over the years, there have been significant findings and evidence 
that naturally-occurring compounds derived from higher plants have the potential to be 
developed as modern therapeutic drugs. 
The search for bioactive compounds from plant-based medicines or organisms for the 
development of conventional drugs are now reviving and becoming more 
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commercialized  in the modern medicine throughout the world. Approximately, about 
25% of the drugs used in the world today originate from higher plants and among them 
were taxol, morphine, quinine caffeine, atropine, and reserpine [5]. 
It is undeniable that products from natural origin still continue to be valuable sources for 
new therapeutic agents especially with the profound understanding of the biological 
significance and mechanism of actions of the active compounds. Until now, about 1% of 
tropical species have been studied and screened for their pharmaceutical potential against 
various diseases including cancer, diabetes and cardiovascular disease [6]. 
Plants and their extracts and derivatives still serve as a major contribution in pharmacy 
and medicine because of the increasing demand for medicines and foods (nutraceuticals) 
from the ageing population especially in Europe, Australasia and North America [7-8].  
As new diseases emerge and the trend for drug resistance and side-effects increases, there 
is the need to discover new medicinal drugs from natural origin with specific targets and 
the least side-effects. On the other hand, synthetic drugs tend to show rapid onset of 
action with more side-effects in comparison to naturally occurring drugs [9]. 
1.2  History of Natural Products 
The use of plants with medicinal properties has a long story in human history and 
folklore medicine since the beginning of mankind where plants and herbs were used to 
treat various  symptom of diseases by the indigenous people and traditional healers [10].  
The documentation of medicinal uses of plants such as Glycyrrhiza glabra (licorice) and 
Papaver somniferum (poppy juice), were first recorded on clay tablets from 
Mesopotamia in about 2600 BC [11].  
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Ayuverda is one of the ancient medicines originated from India which is based on the 
balance of the nature. Ayuverdic plants include Azadirachta indica (neem) and Elettaria 
cardamomum (cardamomum) . Vinca rosea and Taxus spp were among the medicinal 
plants derived from folk medicine  which were traditionally used for the treatment of 
diabetes [12]. 
1.3  Natural Products   
Natural products, also referred as secondary metabolites, are bioactive compounds 
synthesized by natural resources such as plants, marine organisms and microorganism 
primarily as a defense mechanism against herbivores and predators in order to survive in 
their surroundings. Other than that, secondary metabolites may also serve as metal 
transporting agents, as agents of symbiosis, as sexual hormones and as differentiation 
effectors [13-14]. 
Secondary metabolites are naturally occurring products of secondary metabolism from 
primary products such as the carbohydrates, fatty acids and lipids. They possess complex 
carbon skeleton structures and biological properties that are unique to the plant [15]. 
Secondary metabolites are biosynthesized in certain plant species or in specific part of 
the plants. They are not ubiquitous and their occurrences are limited. They also do not 
participate in the biosynthesis of primary metabolites.  
On the other hand, primary metabolites (carbohydrates, amino acids, enzymes, 
nucleotides, etc.) occur naturally in plants and they are essential in the normal growth 
and development of the plants. Secondary metabolites are not required in the vital growth 
of the plant and due to that they are not biosynthesized in a higher concentration and 
usually their presence in plants are affected or induced in response to the surrounding 
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factors, conditions and stress such as the climate, the soil condition, herbivores, etc. [16-
17]. 
Secondary metabolites are grouped according to their structures, biosynthetic pathways 
and the plants which produce them.  Alkaloids, terpenoids and phenolic compounds  are 
the three major groups of secondary metabolites  where alkaloid is the largest class of 
secondary metabolites with over 6,500 known compounds [18]. Alkaloids are 
nitrogenous organic molecules biosynthesized primarily from amino acids such as 
tryptophan, phenylalanine, lysine and arginine. Most alkaloids discovered were found to 
exhibit pharmacological properties such as antimitotic, antibiotic and anti tubercular 
agents [19-21]. 
Terpenoids are important in plants as a defense system against herbivores because of 
their toxicities. The triterpenoid  azadirachtin found abundantly in neem plant 
(Azadirachta indica A. Juss) is a well known natural insecticidal agent [22-23]. Some 
secondary metabolite families are involved in cell pigmentation in flower and seed which 
contribute to plant reproduction. For example, Anthocyanin, a polyphenol antioxidant, is 
a brightly colored pigment in blue and red flowers that attract insects and seed feeders to 
facilitate pollination [24]. Phenolic compounds from plants with antioxidant activity play 
an important role in the prevention of oxidative degradation of lipids by neutralizing the  
free radicals [25].  
Recently, there is an increasing interest in secondary metabolites that exhibit active 
biological properties. Many bioactive secondary metabolites show a variety of 
pharmacological effects like cytotoxic, antibiotic, antifungal, antiviral, antimalarial and 
many others. Some of the well known examples of secondary metabolites with 
pharmacological activities that have been developed as drugs were paclitaxel (anticancer 
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agent) isolated from Taxus brevifolia and salicin ( analgesic agent) isolated from willow 
[26]. 
 
1.4 Drugs from Natural Products 
Plants still and will continue to be the primary source for the discovery of new 
therapeutic agents with pharmaceutical and medicinal properties. Over   than 80% of 
natural products derived from plant origin but only a small percentage from several 
hundred thousand plant species has been investigated phytochemically and 
pharmacologically [27].  
A substantial number of effective drugs have been developed from natural products 
through the discovery of bioactive compounds that were originally isolated from the 
plants or their secondary metabolites. They include paclitaxel, campthotecin, artemisinin, 
mevastatin and etoposide.  
Morphine, an analgesic agent, isolated from Papaver somnifrum (opium poppy) was the 
first alkaloid synthesized in the laboratory in 1816 and this discovery has laid the 
foundation for the beginning of phytochemistry which is the study of chemistry of plants 
[28].  
The history of aspirin went as far back as 500 AD where the Greek physician 
Hippocrates documented a concoction made up from the willow bark that was used to 
treat pain and fever. The Native American Cherokees also used the willow bark to treat 
symptoms of fever. It was later discovered in the 1800s that the analgesic and antipyretic 
properties of the willow bark were actually produced by a compound called salicin. This 
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was then followed by the synthesis of acetylsalicylic acid and marketed under the   trade 
name, aspirin.  
Today, aspirin is not only used to treat pain, fever and inflammation but also help to 
reduce the risk of heart attack and stroke by preventing   platelet aggregation. In the 
United States, over 50 million adults take aspirin regularly for long term prevention of 
cardiovascular disease [29]. 
Quinine which was isolated from the bark of the cinchona tree was another breakthrough 
in drug discovery from plants. Traditionally, it was made a concoction by the native 
Indians in Peru to treat fevers. It was later discovered that it can also treat malaria [30-
31].  
According to a survey on the origin of drugs developed between 1981 and 2002, about 
63% of the drugs sold on the market were either produced directly or synthetically from 
lead compounds of natural products such as plants, microorganisms and marine 
organisms [32-33]. 
In the United States alone, 13 clinical drugs approved between 2005 and 2007 were 
derived from natural products with five of them belongs to the first members of new 
classes [34-35].   
Nitisinone, a derivative from Callistemon citrinus used for the treatment of hereditary 
tyrosinaemia type 1 (HT-1) and galantamine hydrobromide , an Amaryllidacea alkaloid 
from Galanthus nivalis were among the approved drugs in the last 5 years that were 
developed from natural origin [36-37]. Doxorubin and paclitaxel (antitumor agents), 
cyclosporine A and tacrolimus (immunosuppressive agent) and lovastatin (cholesterol 
lowering agent) are among well known and widely used drugs from natural products   
[38-39].   
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This clearly suggests that natural products are important sources for new therapeutic 
agents and they have significantly contributed as lead compounds in drug development 
project. Other than plants, chemical compounds from other biological resources such as 
bacteria, fungi and marine organisms also contribute towards the development of new 
drugs   [40-41]. 
The increasing demand for medicines and health supplements (nutraceuticals) from the 
ageing population has prompted the researchers to discover new bioactive compounds 
from natural products. 
In a report by World Health Organization (WHO), more than 80% of the population of 
the developing countries still depends on traditional medicines from plants for the 
treatment of common symptoms and diseases. To this date, a major part of this world still 
uses traditional medicinal plants in their primary health care. [42-43]. 
The selection of plant materials for bioactive natural products is based on various 
approaches including random screening, ethnobotanical method, chemotaxonomical 
knowledge and ethnopharmacological approach [44-46].  
In the process of drug discovery, random screenings of various compounds in natural 
products are tested initially in vitro or in vivo where subsequently only compounds that 
show significant biological activities and selectivity will proceed to the next level of 
evaluation and clinical trials [47-48].  
The search for pharmaceutical agents through random screening has led to the discovery 
of many beneficial clinical drugs. Vincristine and vinblastine were discovered from 
Catharantus through random screening during the search for potential oral hypoglycemic 
agent [49-50].  
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In the bioassay-guided fractionation approach, the crude extracts of the plants are 
screened first and this is followed by bioassay–guided isolation where every stage of 
fractionation and isolation is guided by bioassays [51-52]. The active chemical 
constituents are then isolated from the bioactive fractions and the structures of the active 
compounds are further determined and identified by structural elucidation using 
chromatographic and spectroscopic methods such as NMR, 2D NMR, UV, IR and MS . 
Another method is through chemotaxonomical approach that utilizes the previous 
informations of a certain group of plants with specific chemical compounds  to  establish  
the compounds in another plant in the same taxanomic group [53]. 
Dereplication is a process where recurrence of similar or known compounds is avoided 
by differentiating between known and unknown compounds. This is done through the use 
of high throughput screening (HTS) by applying hyphenated techniques such as the 
liquid chromatography–electrospay ionization–mass spectrophotometry (LC/ESI/MS), 
liquid chromatography-photoiodide array detection (LC/PDA) and liquid-
chromatography-nuclear magnetic resonance (LC/NMR) chromatography where 
unknown compounds are identified in a shorter time without the need for extensive 
purifications compared to the traditional method [54-55] . 
Recently, there was an effort to establish a database for the dereplication of natural 
products mixture to facilitate fast identification of known compounds and to provide 
some insight to unknown compounds [56]. 
It is quite a major effort to isolate bioactive pure compounds from plants and organisms 
due to their complex molecules especially in the case of secondary metabolites which are 
usually not found in a larger amount. Most of the time, the isolated pure compounds were 
yielded in a very small quantities (in nanograms) which are not enough for further 
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structural elucidations and bioactivity tests. In general, at least 3mg of sample is required 
for NMR analysis.  
 It would be ridiculous to harvest a massive volume of raw plant materials as this may 
result in the extinction of the species and causing environmental disturbances. 
Furthermore, the process of extracting and isolating each pure compound are often time-
consuming and require expensive chemical solvents, reagents and tools. Not to mention 
the capacity, efficiency and sensitivity of the instruments used for structural elucidation 
that also should be considered.  
Thus, this problem is usually overcome by synthesizing the compounds in the 
laboratories in a larger amount where lead compounds from natural products are 
chemically synthesized by molecular modification of the functional groups to generate 
structural analogue [57-58]. 
Another alternative is to use plant tissue culture technology to specifically increase the 
production of secondary metabolites at a larger scale [59]. For example, several studies 
have demonstrated that paclitaxel can be produced and purified from plant cell cultures to 
yield a larger quantity and higher purity of the compounds [60-61]. 
To this date, with a keen interest in natural products, scientists and researchers from all 
backgrounds have continuously screening plants and other organisms to discover   the 
lead compounds for antioxidant, anticancer and antimicrobial agents including other 
significant pharmaceutical agents. 
The search for pure compounds with biological activities from plant-based medicines or 
organisms for the development of potential drug candidate are now expanding   in the 
field of modern medicine throughout the world especially with more plants and 
organisms being screened.  
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In fact, with the latest development, plant cell cultures can be genetically developed to 
produce the selective bioactive metabolites which can be produced in larger volume and 
cost effective [62-63]. 
 
 1.5 Natural Antioxidants  
Plants contain several compounds that possess antioxidant activity. Natural antioxidant 
compounds in plants play an important role in scavenging free radicals. Free radicals 
include hydrogen peroxide, hydroxyl radicals and superoxide anions. They are the by-
products of biological redox reaction in the cellular system that are formed from 
environmental factors such as environmental pollutions and contamination, UV light, 
cigarette smoke, chemicals and toxic waste [64-65]. 
The free radicals are highly reactive chemicals with an odd or unpaired electron that can 
attack the cells to stabilize the odd electron.  This reaction will result in cell damage and 
tissue injury that will eventually cause a number of diseases and disorders such as heart  
disease, cancer, chronic lung diseases (CKD), stress, aging and neurovascular diseases         
[66-67]. 
However, this occurrence can be prevented with diets rich in antioxidant compounds. It 
was shown that foods like fruits, vegetables , tea and red wine that contain high amount 
of antioxidants such as tocopherol and carotene were able to reduce the risk of heart 
disease and cancer [68]. These days, antioxidants are now considered as important 
nutraceuticals in the human diet in disease prevention  [69-70]. 
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Scientific evidence has demonstrated that diets rich in vitamin C, vitamin E and phenolic 
compounds play an important role in controlling oxidative stress, cardiovascular disease, 
muscle atrophy and inflammation [71-72].  
Other studies also found that antioxidants contribute greatly in preventing the 
accumulation of reactive oxygen species that can cause cellular damage to the DNA, 
proteins and nucleic acids [73]. There were also reports that natural antioxidants can 
delay or prevent degenerative diseases such as Alzheimer’s and Parkinsons’ and increase 
the human lifespan [74-76]. 
Primary sources of natural antioxidants such as phenolic compounds and flavanoids can 
be found mostly in fruits, vegetables, nuts and grain. Vitamin C, vitamin E, carotenes and 
phenolic acids are among plant sourced antioxidants [77]. Phenolic and polyphenolic 
compounds are the main class of natural antioxidants that are found mostly in fruits, 
vegetables, legumes and grains. They exist as substituted benzoic and cinnamic acid 
compounds [78]. Even though there are synthetic antioxidant compounds on the market 
such as butylated hydroxytoluene (BHT) and butylated hydroxyanisole (BHA), which are 
commonly used in the food industry, there were some evidence that these chemicals can 
produce side effects with long term consumption [79]. Therefore, more attention is given 
now towards the discovery of new natural antioxidants from natural products.  
1.6 Cancer 
Cancer is a disorder characterized by rapid multiplication of normal cells which develop 
into uncontrolled growth that eventually led to death. There are many types of cancer and 
its symptoms depend on the catogories of malignancy and how advanced is the process 
of metastasis. In developed countries, cancer is one of the dominant causes of death with 
thousands of patients succumbing to death each year from different types of cancer.  
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The World Health Organization (WHO) estimated that 7.6 million of deaths in 2005 were 
caused by cancer with the majority of cases from lung, stomach and breast cancer [80].  
In the United States, cancer is the second leading cause of death where one in four deaths 
is due to cancer that include children and adolescents [81]. It was estimated that there 
were 10.9 million new cases, 6.7 million deaths, and 24.6 million persons living with 
cancer around the world [82]. According to the World Cancer Report in 2003, the rate of 
cancer cases was expected to increase by 50% to 15 million new cases in the year 2020 
[83]. 
Back in 1960, the United States National Cancer Institute (NCI) has initiated an 
extensive plant collection program leading to the discovery of numerous novel cytotoxic 
agents, including the taxanes and camptothecins.  
To date, the National Cancer Institute has accumulated about 35,000 plant samples from 
20 countries and has screened around 114,000 extracts for anticancer activity [84]. Taxol, 
vinblastine , vincristine, topotecan and irinitecan, camptothecin derivatives and 
eitoposide are among the anticancer agents discovered from plant origin [85].  
The search for anti-cancer agents has evolved and expanded to a higher level ever since 
the discovery of vinblastine and vincristine (natural alkaloids). Vincristine and 
vinblastine were two vinca alkaloids discovered from the Madagascar periwinkle, 
Catharantus roseus from family Apocynaceae. These were two famous anticancer agents 
which have advanced successfully through clinical trials and at present they are clinically 
used for the treatment of lymphoma and leukemia [86]. 
Another amazing discovery of anticancer agent from natural products was Taxol, which 
was isolated from the bark of Taxus brevifolia from family Taxaceae. Camptothecin, a 
natural alkaloid isolated from Camptotheca acuminate is used as chemotherapeutic agent 
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in the treatment of stomach, colon and bladder cancers [87]. Aside from plants, more 
studies are now looking at marine organisms as potential source for anticancer drugs. 
Some of the new anticancer compounds from marine sources are cryptophycin, aplidine 
and Halicondrin B [88-90]. 
Approximately about 74% of the anticancer drugs on the market are either natural 
products or of a natural origin [91].  Currently, there are nine plant-derived anticancer 
drugs that have been approved for cancer treatment which are vinblastine, vincristine, 
etoposide, teniposide, taxol, navelbine, taxotere, topotecan and irinotecan [92]. Up until 
now, many higher plants have been screened and evaluated to identify new and effective 
drug for the cancer chemoprevention, as well as to elucidate the mechanisms of cancer 
prevention and apoptosis.    
Quite a number of studies have also reported that extracts from natural products such as 
fruits, vegetables and medicinal herbs have positive effects against cancer. For example, 
some of the flavanoids such as kaempferol and genistein showed antiproliferative activity 
[93]. Quercitin, a flavanoid found mostly in fruits and vegetables demonstrated anti-
tumor effect including increasing the effectiveness of some chemotherapeutic agents 
through synergistic effects [94]. 
Recent studies of plant extracts that have been studied  and have shown  cytotoxic effects 
on cancer cell lines include those of Solanum lyratum which were tested on human colon 
adenocarcinoma cell line (colo 205) [95], Annona glabra on human leukemia cell lines 
(CEM/VLB) [96] and Artocarpus altilis on human breast cells (T47D) [97]. 
There is an upward trend of interest from the pharmaceutical and commercial industries 
in the continuing discovery of new anticancer agents from plants especially for natural 
compounds that can overcome the problem of multi drug resistance (MDR) in cancer 
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chemotherapy [98]. The search for an effective anticancer drug based on natural products 
has been actively carried out   all over the world including Malaysia. 
 
1.7 Natural Products in Malaysia 
Malaysia  ranks  the 12th largest in the world in term of biodiversity [99] . More than 
60% of the woods in the Malaysian tropical forest are processed and commercially 
exported to other countries. Apart being the main source for timber industry, Malaysian 
tropical forest too is rich with all kinds of plants and flora with medicinal properties 
which have long been utilized by the local people and traditional practitioners.  
Among the popular traditional medicinal plants were Eurycoma longifolia (Tongkat Ali) 
which is scientifically known to increase male potency and Labisia pumila (Kacip 
Fatimah) which is commonly used as postpartum medication for women.  In term of 
commercial purposes, these two herbs are commonly added in coffee mixtures as health 
supplements, and widely consumed by the consumers. Indigenous people in Malaysia, 
Orang Asli, used the bark of Tongkat Ali ( Eurycoma longifolia) to treat small pox and 
malaria [100] . Other plants used traditionally include Kacip Fatimah (Labisia sp.), 
mempisang (Gonothialamus sp) and bunga pakma (rafflesia hasselti) [101]. 
 In Sabah, about 30% of traded non-timber forest products sold in the local markets 
(tamu) was sourced from medicinal plants as part of the socio-economic activity. These 
include akar mengkudu (Morinda citrifolia), tongkat ali (Eurycoma longifolia) etc. 
It would be a great loss if we do not take this opportunity to screen our natural products 
for active chemical compounds especially when the technology is made available to us. 
On top of that, the Government of Malaysia has given more priorities in the scientific 
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research field by providing more funds and incentives. Therefore, it is imperative that we 
evaluate our natural products and compile the data for future reference and scientific 
research as part of our contribution to the world of knowledge. 
 
1.8   Selection of Plant for the Study 
1.8.1 Previous work 
One study was previously done on the chemical constituents of Pseuduvaria rugosa 
(KL4709) by Rosmahaida Jamaluddin back in 1999 which has described the isolation 
and identification of nine compounds with most of them were alkaloids [102]. 
1.8.2   Justification of present study  
Pseuduvaria rugosa was selected for the study because literature survey revealed that 
there was only one thesis documentation on the chemical constituents from the stem bark 
of Pseuduvaria rugosa (KL 4709) which was not published in any journal and so far to 
the best of the author’s knowledge, there has not been any report on the biological 
activities of any chemical compounds found from Pseuduvaria rugosa.  From the 
literature review, the number of Pseuduvaria species that have been chemically 
investigated is still very small and only a few biological activities of some compounds 
were reported. 
In other Pseuduvaria species, alkaloids from Pseuduvaria setosa was reported to possess 
strong anticancer activity against epidermoid carcinoma (KB) and breast cancer cell (BC) 
cell lines. Interestingly, in the taxanomic approach, Pseuduvaria rugosa shared the same 
class of phylogeny and similar DNA characteristics as Pseuduvaria setosa. Previously, 
most of our research and studies have concentrated on identifying the chemical 
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compounds in the higher plants, but now studies are more oriented on investigating the 
biological activities of the phytochemicals as well. 
In ethnobotanical context, the plant is not traditionally known to possess medicinal 
properties among the locals though it belongs to the family Annonaceae which is known 
to exhibit pharmacological properties. Furthermore, little was known about the medicinal 
value of this plant though there were claims that this plant may possess anticancer agents 
which were earlier reported from Pseuduvaria setosa. Hence, this study can provide the 
data and information on the chemical constituents and biological activities in comparison 
with that of Pseuduvaria setosa and other Pseuduvaria species.   
In this study, the sample of Pseuduvaria rugosa was collected from a different location 
and given a different voucher number which was not the same in the previous study. 
Again, this study can provide more data and information on the chemical compounds and 
profile of Pseuduvaria rugosa that was collected from a different location. 
This study was also not intended to focus on the alkaloid compounds of the plant only 
but also on other class of compounds. In addition to that, GC/MS analysis was also 
carried out to investigate the compounds present in the hexane extract of Pseuduvaria 
rugosa.  
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1.9   Objectives of the study 
In consideration of the above facts, the main purpose of this study is to investigate the 
chemical constituents of Pseuduvaria Rugosa (Annonaceae) and evaluate the biological 
activities of the crude extracts and the isolated compounds: 
a) To investigate and isolate the chemical constituents from the bark of 
Pseuduvaria rugosa using chromatographic methods 
b) To identify the isolated compounds by structural elucidations using UV, 
IR, H-NMR, 13CNMR, 2D NMR and mass spectrometers. 
c) To evaluate the antioxidant and anticancer activities of the crude extracts 
and identify the active compounds.  
d) To report and publish the data and information on the chemical 
constituents and biological activities of Pseuduvaria rugosa . 
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CHAPTER TWO 
GENERAL CHEMICAL ASPECTS AND BIOLOGICAL ACTIVITIES 
 
2.1 Classification and taxanomy of Pseuduvaria genus [103] 
         Kingdom    :   Plantae 
         Division       :  Magnoliophyta 
         Class            :  Magnoliopsida 
         Order           :  Magnoliales 
         Family          :  Annonaceae 
         Genus           :  Pseuduvaria  
         
2.2   The Annonaceae Family 
The family Annonaceae is one of the largest family of the flowering plants from 
magnolia order (Magnoliales) which consists of approximately 128 genera and over 
2,220 species [104]. 
There are about 51 genera and 950 species of the Annonaceous plants in Asia and 
Australia,  40 genera and  450 species in Africa, and 38 genera and 740 species in the 
American continent [105].   
In Malaysia, there are 38 genera, 198 native and 5 cultivated species including 17 
varieties of Annonaceae plants  and they are abundantly found in the lowland forests 
mostly below 2,000 feet  [106]. 
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The members of the Annonaceae family are made up of small trees, shrubs and woody 
climbers that be found mainly in the tropical and subtropical regions [107].  The plants 
from Annonaceae family have been known to be rich in alkaloids especially the 
isoquinoline alkaloids where they are found mainly in most parts of the plants [108-109].  
Most of the species from Annonaceae were used in folk medicine and many of the 
compounds isolated have exhibited potent biological activities such as cytotoxic, 
antitumor, antimalarial, antibacterial, antifungal, antiplatelet aggregation and 
immunosuppressive activities [110-113]   .  
Traditionally, the plants of Annonacea (mempisang) have been used by the local healers 
to treat symptoms of fever and stomachache. And recently, they were claims that the 
plants can be also used in the treatment of cancer. 
 
2.2.1 Vernacular names [114] 
1. Akau (Sarawak) 
2. Antoi , jangkang (Peninsular Malaysia) 
3. Pisang-pisang, mempisang (Peninsular Malaysia and Sabah) 
4. Mempisang (Brunei) 
 
2.2.2 Economic value 
In Malaysia, the Annonaceae family is locally identified by the foresters and traditional 
healers as Mempisang. Another local name is akar larak that describes the climbing 
plants which is known among the traditional practitioners for mystic purposes.  Apart as 
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a source of firewood, the Annonaceous woods are used in the furniture making, packing 
cases and crates, while the heavier species are used for parquets and strip flooring [115].  
 
2.2.3 Pharmacological value 
The members of Annonaceae family are reported to contain secondary metabolites 
including acetogenins, terpenoids, phenolics and alkaloid compounds with various 
biological activities [116-117]. Recently, there has been a growing interest in the species 
of the Annonacea family in the pharmaceutical research and ethnobotanical investigation 
[118]. In a literature review, 319 secondary metabolites have been reported  from 150 
species of the Annonaceae that include alkaloids , non-alkaloid compounds and essential 
oils [119].  
These secondary metabolites with interesting biological activities can be potential 
pharmaceutical agents for the treatment of cancer, microbial infection, hypertension and 
brain dysfunctions. For example, goniotriocin , an annonaceous acetogenin isolated from 
Goniothalamus giganteus, showed potent and selective cytotoxicity against six human 
tumour cell lines [120]. Benzylisoquinoline alkaloids isolated from Annona salzmanii DC 
have antibacterial and antifungal activities [121] . 
Annonaceous plants have been used by traditional healers for medicinal purposes such as 
stomachache, asthma, cough, fever and wounds [122-123] .  
In the tropical region, about 50 species of the Annonaceae are commonly used for the 
treatment of fever, stomach ailment and skin problems. In a recent documentation of 
traditional medicinal plants in Sabah, Annonaceae plant or Mempisang  was listed as one 
of the local medicinal plants regularly used by the local healers to treat clinical symptoms 
[124]. 
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2.3 Genus Pseuduvaria 
Pseuduvaria is a rainforest plant species that is incorporated in the family Annonaceae. 
Plants in this genus are in the major group of    flowering plants ( Angiosperms) that are 
made up of shrubs and trees usually found in the rainforest population [125].  It was 
reported that the Pseuduvaria species originated from Sundaland in the late Miocene and 
later migrated to the other part of the region [126].  
The Pseuduvaria species are commonly found in Malaysia, Thailand, Burma, and 
Indonesia and in the northeastern part of Queensland, Australia (Figure 2.1). Currently, 
there are about 52 Pseuduvaria species that were classified and documented (Figure 2.2) 
but only a few have been investigated chemically and biologically. 
The Pseuduvaria genus was formerly known as  Orophea rugosa, Mitrephora rugosa 
and Uvaria rugosa due to their close resemblances and similar morphological 
characteristics [127].  They are known to contain both alkaloid and non-alkaloid 
compounds, including essential oils.  Some of the Pseuduvaria species are traditionally 
used in treating cough, fever and stomach ailments. 
Previous researches have revealed the presence of alkaloids in most Pseuduvaria species 
that were studied. Some of the alkaloids found in the Pseuduvaria species include 
liriodenine, anonaine, nornuciferine, etc. Some studies have also demonstrated that crude 
extracts and alkaloids isolated from Pseuduvaria species  exhibit biological and cytotoxic 
activities [128]. 
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                Figure 2.1: Distribution of Pseuduvaria species in South East Asia                       
                                    (indicated in pink color) [126]. 
 
 
 
 
. 
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                      Figure 2.2 :  Chronogram of Pseuduvaria  species  [127] 
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2.4 Pseuduvaria rugosa 
2.4.1 Morphological description  
The tree is 5-7 m high with slender and dark colored young twigs. The leaves are simple 
and alternate, membraneous and papery with lanceolate shape (spear shaped). The fruits 
are small which look like a bunch of berries consist of a group of fleshy carpels that is 
attached on a torus. (Figure 2.3). The bark is fibrous and aromatic, smooth and grey to 
brown in color (Figure 2.4).  
The flowers are bisexual and influorescences which are arranged in axillary fascicles 
either solitary, paired or clustered and they are characterized by a cyclic perianth of three 
trimerous whorls, an androecium of several stamens and a gynoecium of free carpels on a 
flat or conical receptacle [129].  
In Pseuduvaria species, the flower is mostly solitary (outer petals 1–1.5 cm, shorter than 
inner petals). The pollen of 42 species of Pseuduvaria is described as inaperturate, 
isopolar and radically symmetrical [129]. Figure 2.5 illustrates some of the flowers and 
fruits from Pseuduvaria species. 
 
2.4.2 Distribution 
Pseuduvaria rugosa is distributed in Malaysia, Thailand, Indonesia and Borneo. In 
Malaysia, Pseuduvaria rugosa can be found in Selangor, Malacca, Perak , Perlis, Pulau 
Pinang and Kelantan [130]. 
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Figure 2.3: Fruits and flower of Pseuduvaria rugosa 
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Figure 2.4: The stem bark of Pseuduvaria rugosa 
 
Figure 2.5: Some of the fruits and flowers of Pseuduvaria species 
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2.5 Chemical aspects of Pseuduvaria species 
In the past years, a number of phytochemical constituents including alkaloids, terpenoids 
and essential oils have been isolated and characterized from several Pseuduvaria species. 
Literature reviews indicated that only several species in the genus Pseuduvaria have been 
investigated for its chemical components. And recently, researchers are also interested in 
looking into their biological activities. 
Previous researches have revealed the presence of alkaloids in most Pseuduvaria species 
that were studied. Some of the alkaloids commonly found in the Pseuduvaria species 
include liriodenine, ouregidione, anonaine, nornuciferine, O-methylmoschatoline etc. 
Previous investigation on the stem bark of Pseuduvaria rugosa (KL 4709) by 
Rosmahaida (1999) have described the isolation and characterization of nine compounds, 
of which seven of them were alkaloids [102]. The isolated alkaloid compounds were 
liriodenine 1, atherospemidine 2, oxoputerine 3, 3-methoxycepharadione-B 4, 
ouregidione 5 and norcepharadione B 6. Rugosanine 7 was a new alkaloid with an 
aldehyde group at C-7. In addition to that, two chromans namely rugosin-A 8 and 
rugosin-B 9 were isolated from the petroleum-ether extract. However, there were no 
biological activities reported. 
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In another investigation of Pseuduvaria macrophylla , two aporphinoid alkaloids were 
isolated from the stem bark of Pseuduvaria macrophylla  that were collected  in the 
primary forest close to Taman Negara, Pahang, Malaysia [131] and no biological activity 
was reported. 
The two compounds were are O-methylmoschatoline 10 and N-Methylouregidione 
(1,2,3-trimethoxy-4,5-dioxo-6a,7-dehydraporphine) 11. Medicinally, the roots of 
Pseuduvaria macropylla was used as one the essential concoction for the treatment of 
stomach ailment [132]. 
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Pseuduvaria setosa (King) J. Sinclair is another species of Pseuduvaria genus that has 
been investigated. In Malaysia, the fruits of Pseuduvaria setosa are normally consumed 
by fruit bats as one of their main diets during the fruiting season [133]. 
In Thailand, Pseuduvaria setosa is found in the southern part of the country. There were  
two dioxoaporphine alkaloids isolated, N-methylouregidione  11 and ouregidione  5  and 
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two oxoaporphine alkaloids, liriodenine 1 and oxostephanine 12 from the aerial part of 
Pseuduvaria setosa (King) J. Sinclair [134]. 
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Phytochemical investigation  on the stem bark of Pseuduvaria indochenesis  [135]  has 
led to the isolation and characterization of a novel protoberberine alkaloid, 
dehydroscoulerine 13, and scoulerine 14 along with three other known oxoaporphine 
alkaloids, liriodenine 1, atherospermidine  2 and oxoanolobine  15. 
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Three diterpenes were isolated from the stem bark of Pseuduvaria indochinensis and 
identified on the basis of spectroscopic data and x-ray diffraction resulted as ent-8α-
hydroxypimar-15-en-18-oic acid 16, ent-pimaric acid 17, and ent-16α,17-
dihydroxykauran-19-oic acid 18.  Both 16 and 17 appeared to be novel [136].   
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The alkaloids found from Pseuduvaria cf. grandifolia were liriodenine 1, anonaine 19, 
and nornuciferine 20 and from  Pseuduvaria cf. dolichonema , the alkaloids found were 
glaucine 21, 2-hydroxy-1,9,10- trimethoxynoraporphine  22 and norglaucine 23 [137]. 
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In Australia, a study was done on the essential oils of the leaf of Australian species of 
Pseuduvaria. The species investigated were Pseuduvaria mulgraveana var. 
mulgraveana, Pseuduvaria mulgraveana var. glabrescens, Pseuduvaria hylandii, 
Pseuduvaria villosa, and Pseuduvaria froggattii. [138].  
These species are mainly found in the wet tropics of northeastern Queensland [139]. 
Some of the compounds  present in the leaf oils of the Pseuduvaria species  include  β-
caryophyllene 24, α- curcumene 25, α- copene 26, elimicin 27, methyl eugenol  28, 
spathulenol 29, caryophyllene oxide 30 and froggart ether (a fourt dihydroagarofuran 
isomer) 31. β-caryophyllene 32, a sequisterpene found in essential oils has been reported 
to potentiate the anticancer activity when combined with paclitaxel [140-141]. 
 
 
  
36 
       
H
H
                                               
               24                                                                                 25 
 
  
H
H
H
                                              
OCH3
OCH3
OCH3
                                             
            26                                                                                     27 
 
  
OCH3
OCH3
                                            
H
O
H
H
 
             28                                                                                     29     
 
  
  
37 
 
       
H
H
O
H
                                           
O
 
                    30                                                                     31 
 
 
                                   
                                                        32                                                       
 
 
 
 
 
  
38 
2.6 Biological Activities of Pseuduvaria Genus 
Several studies have demonstrated that crude extracts and alkaloids isolated from 
Pseuduvaria species exhibit biological and cytotoxic activities. 
M. Othman et al (2009) studied the antimicrobial and antioxidant activities of the crude 
extracts (hexane, ethyl acetate and ethanol) of Pseuduvaria macrophylla. The 
antimicrobial activity was evaluated by agar-based pour plate disc diffusion (PPDD) and 
broth -based turbidometric (TB) assay [142].   
The investigation revealed that the crude extracts of Pseuduvaria macrophylla showed 
antimicrobial activity against two gram negative strains, (Escherichia coli and 
Citrobacter freundii) and four gram positive strains (Staphyllococcus aureus, 
Staphyllococcus epidermis, Bacillus cereus and Bacillus subtilis) in a dose depending 
manner. 
In the antioxidant test , all crude extracts showed high antioxidant activities in the β-
carotene bleaching (BCB) assay test comparable to trolox and quercetin, but in  Ferric 
Reducing Antioxidant Properties (FRAP) test, only the ethanol extract was active than 
the hexane and ethyl acetate extracts. However, the chemical compounds responsible for 
the bioactivities, have yet to be isolated. 
In Thailand, the root of Pseuduvaria setosa has been traditionally used to treat cough and 
fever [143]. Biological activities of the four alkaloids, N-methylouregidione 11, 
liriodenine 1 and oxostephanine 12 , isolated  from the aerial part of Pseuduvaria setosa 
showed in vitro antituberculosis activity against Mycobacterium tuberculosis with MIC 
values of 100, 12.5 and 25 g/ml , respectively [134].   
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These results have demonstrated that aporphine alkaloids can be developed as potential 
anti-tubercular agents in chemotherapy [144]. In the same study, liriodenine 1 isolated 
from Pseuduvaria setosa displayed antimalarial activity against Plasmodium falciparum 
(K1, multidrug-resistant) with 50% inhibitory concentration (IC50) of 2.8 µg/ml. 
In the cytotoxic study of Pseduvaria setosa, liriodenine 1 and oxostephanine 12 showed 
strong cytotoxic activity against epidermoid carcinoma (KB) and breast cancer (BC) cell 
lines, whereas ouregidione 5 was moderately active against BC cells. Both N-
methylouregidione 11 and ouregidione 5 were active against small cell lung cancer (NCI-
H187) cell line and were able to stimulate lymphocyte proliferation with stimulation 
indices (SI) of more than 1.  
In another study on bioactivity, ethanol crude extracts from Pseuduvaria setosa was 
found to stimulate lymphocyte proliferation in in vitro immunostimulating activity test. 
The isolated pure compounds, i.e., kaurenoic acid 33, β-sitosterol 34, quebrachitol 35, 
and ouregidione 5   were capable to enhanced IL-12 secretion from J774A. 
Diterpenes, ent-8α-hydroxypimar-15-en-18-oic 16, ent-pimaric acid 17, and ent-16α,17-
dihydrokauran-19-oic acid 18  isolated from Pseuduvaria indochenesis was found to 
inhibit DNA topoisomerase activity [136] . 
COOH HO
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                                                        CHAPTER THREE 
RESULTS AND DISCUSSION 
 
3.1  Phytochemical study of Pseuduvaria rugosa (Annonacea) 
The stem bark of Pseuduvaria rugosa (KL 5186) has been studied for its chemical 
constituents and biological activities. This species belongs to the family Annonaceae. 
Phytochemical investigation on the stem bark of Pseuduvaria rugosa was carried out 
through the extraction, separation, structural elucidation and biological activity test. 
The extraction of the plant sample has been conducted using hexane, followed by 
dichloromethane and acid-base extraction to yield crude alkaloid and finally with 
methanol.  
The dried and grounded stem bark of Pseuduvaria rugosa was first defatted with 
hexane to remove chlorophyll and lipid matters using Soxhlet extractor. The plant 
residue was moistened with ammonia and extracted with dichloromethane. 
Dichloromethane extract was then concentrated to about half of it original volume 
and then extracted with 5% hydrochloric acid.  
The hydrochloric acid extract was basified with ammonia followed by extraction with 
dichloromethane. Then the crude dichloromethane extract was evaporated to dryness 
to give crude alkaloid. The plant residue was re-extracted with methanol and 
evaporated to dryness to give crude methanol extract. All the crude extracts were 
subjected to TLC, column chromatography and HPLC analysis. The hexane extract 
was subjected to GC/MS analysis. 
The structures of the pure phytochemical compounds were established through UV, IR, 
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1D and 2D NMR and MS analysis, and also by comparing data and mass spectral from 
previous published literature. 
This work has led to the isolation of seven compounds from the alkaloid and methanol 
crude extracts. 
 The six compounds were aporphine alkaloids of which three of them are known 
compounds, Liriodenine 1, Ouregidione 5 and N-methylouregidione 11 and the other 
three are new aporphine alkaloids, Pseuduvarine A 36, Pseuduvarine B 37 and 
Pseuduvarine C 38. One new non-alkaloid compound, Pseuduvarin 39 which belongs to 
the benzo [7] annulene skeleton has also been isolated from this plant.  
GCMS analysis of the hexane extract revealed 5 major compounds which are elemicin 
24, isoelimicin 40, 1,2,3,4-tetramethoxy-5-(2-propenyl)benzene 41 , 3- Hydroxy-1-
propenyl-2-methoxyphenol 42,  stigmasterol 43 and γ-sitosterol 44. Other minor 
compounds were spathulenol 29, caryophyllene oxide 30, selina-6-en-4-ol, asarone, 
palmitic acid and ethyl 9-octadecenoate.  
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3.2  PR1:   Liriodenine 1 
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PR1 was crystallized from hexane-EtOAc as yellow needles with melting point at 270-
271oC (Lit. 279-281oC) [145]. It showed bright yellow fluorescence under the UV light 
and gave a positive reaction to Dragendorff’s test with the appearance of orange spot. An 
oxoaporhinic nature was deduced based on the formation of deep red coloration when 
dissolved in trifluoroacetic acid. 
 The oxoaporphine skeleton was deduced by its UV spectrum that exhibited absorption 
bands at 255, 276 (shoulder), 327 and 401 nm indicating a highly unsaturated 
chromophoric system of aporphine alkaloids.  
Its mass spectrum showed a pseudomolecular ion peak [M+H]+ at m/z 276.0448 
corresponding to the molecular formula of C17H9NO3 (Figure 3.1). The loss of 
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formaldehyde [M-CHO] + can be observed at m/z 247 followed by the loss of CO at m/z 
219 [M-CO] + which indicated the presence of methylenedioxyl group in the compound 
(Figure 3.2). These fragmentations provide important information to confirm the 
structures of aporphine alkaloids.  
The infrared spectrum (IR) showed the absorption peak at 1651 cm-1 due to the presence 
of carbonyl group and the peak at 1309 and 1261 cm-1 was observed which is a 
characteristic of methylenedioxyl group (Figure 3.3).  
The 1H NMR spectrum (CDCl3 400 MHz) (Figure 3.4) showed the characteristic of the 
AB system for H-4 and H-5 peaks. The H-4 and H-5 peaks were observed at δ 7.77 and 
δ 8.89 as doublet (J = 5.0 Hz), respectively. A singlet with one proton appeared at δ 7.19 
was assigned to proton at C-3. Another singlet with two protons was also observed at δ 
6.36 which belongs to a methylenedioxyl group attached at C-1 and C-2.  
A peak appeared as a doublet was observed at δ 8.58 (J = 7.8 Hz) corresponding to 
proton at C-11. The H-8 appeared at δ 8.64 as a doublet with J=8.3 Hz and it is more 
deshielded compared to H-11 due to the adjacent carbonyl group at C-7. Two set of 
triplet signals were observed at δ 7.57 with J=7.5 Hz and δ 7.76 with J=8.2 Hz which 
were attributable to H-9 and H-10, respectively. 
The 13C NMR spectrum (Figure 3.5) revealed a total of 17 carbon signals that consisted 
of one sp3 carbon and 16 sp2 carbons.  The sp3 carbon belongs to the methylenedioxyl 
group which was observed at δ 102.56.   
The C-3 signal appeared at δ 103.36 while the  methine carbons C-4, C-9, C-11, C-8, 
C10  and C-5 signals were observed at δ 124.3, 127.5, 128.7, 128.9, 134.1 and 145.0, 
respectively. The carbonyl carbon appeared at very low field which is at δ 182.5. The 
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detailed analysis of quaternary carbons is tabulated in Table 3.1. 
Finally, comparison of this spectroscopic data with those reported in the literature 
confirmed that PR1 was a known compound identified as liriodenine 1 which was also 
discovered in Pseuduvaria rugosa (KL 4709), Pseuduvaria setosa and Pseuduvaria 
indochenesis. 
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Table 3.1: 1H (400 MHz) and 13C NMR (100 MHz) Spectral data of PR1 in CDCI3  
POSITION 1H,  δ ,  (J, Hz) 13C, δ 
1 - 140.8 
1a - 123.5 
1b - 108.0 
2 - 152.0 
3 7.19, s 103.4 
3a - 136.0 
4 7.77, d, 5.0 124.3 
5 8.89, d, 5.0 145.0 
6a - 145.5 
7 - 182.5 
7a - 131.5 
8 8.64, d, 8.3 128.9 
9 7.57, t, 7.5 127.5 
10 7.76, t, 8.2 134.1 
11 8.58, , 7.8 128.7 
11a - 133.0 
-O-CH2-O- 6.36, s 102.6 
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Figure 3.1: A) Mass spectra  and B) UV spectra of PR1 
 
 
 
A) 
B) 
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Figure 3.2  : MS/MS  of PR1 
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Figure 3.3 : IR Spectrum of PR1 
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Figure  3.4 : 1H NMR spectrum of PR1  in  CDCl3 
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                                    Figure 3.5 : 13  C  NMR spectrum of  PR1  in CDCI3 
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3.3  PR2 :  Ouregidione 5
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Compound PR2 was afforded as orange amorphous solid and decomposed at 262oC. The 
UV spectrum (Figure 3.6) exhibits maximum absorption at 213, 229, and 488 nm 
indicating a highly conjugated system. An absorption maximum or shoulder between 
252 and 265 nm is a diagnostic for dehydroaporphine. 
Its mass spectrum (Figure 3.6) established its pseudomolecular ion peak at m/z 338.077 
[M+H]+ corresponding to the molecular formula of C19H15NO5, thus implying highly 
unsaturated. The MS/MS spectrum displayed the fragmentation ions at m/z 322, 321 and 
309.  
The peak at m/z 322 is consistent with the loss of methyl group [M-CH3] + from one of 
the aromatic methoxyl substituents. The following ion fragmentation showed the 
elimination of a carbonyl group [M-CO] +   at m/z 309 (Figure 3.7).  
The IR spectrum showed a conjugated ketone or six member ring lactam at 1733, 1667 
and 1455 cm-1. The presence of N-H group is evidenced from the absorption peak at 
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3584 cm -1 (Figure 3.8). 
The 1H NMR (400 MHz) (Figure 3.9) of PR2  measured in deuterated trifluroacetic acid 
(TFA) as solvent showed the presence of three methoxyl signals appearing as three 
singlets with the intensity of three protons each at δ 4.73, 4.52 and 4.49, and positioned 
at C-3, C-2, and C1, respectively.  
Among the aromatic protons, the signal for H-11 is shifted to a lower field, which is at δ 
9.84 as a doublet with J= 8.5 Hz. This circumstance is typical since C-1 is substituted 
with a methoxyl group in ring A. The peak at δ 8.73 appeared as one proton singlet 
belongs to proton at C-7.  
Another peak appeared as one proton doublet at δ 8.42 with J = 8.5 Hz was assigned for 
H-8.  The peak at δ 8.09 appeared as a one proton triplet belongs to H-9 and the proton 
signal at δ 8.19 appeared as a triplet was assigned for H-10 (Figure 3.10). The details of 
1H NMR data of PR2 are summarized in Table 3.2. 
 
Based on the spectral data of PR2 and comparison with the literature value [134] , it is 
confirmed that PR2 is a known alkaloid identified as ouregidione 5 which was 
previously isolated from Pseuduvaria rugosa (KL 4709) and Pseuduvaria setosa . 
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 Table 3.2 : 1H NMR Data of PR2 (400 MHz) in CDCl3 
Position      1H, δ, (J, Hz) 
       
     1 
1a 
1b 
2 
3 
4 
5 
6a 
7 
7a 
8 
9 
10 
11 
11a 
     C1-OCH3 
      C2-OCH3 
      C3-OCH3 
 
- 
- 
- 
- 
- 
- 
- 
- 
8.73, s, 1H 
- 
8.42, d,1H, 8.5  
8.19, t, 1H, 8.5 
8.09, t, 1H, 8.5 
9.84, d, 1H, 8.5  
- 
4.49, s 
4.52, s 
4.73, s 
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Figure 3.6:  A) Mass spectra and B) UV spectra of PR2 
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                                      Figure 3.7 : MS/MS  of PR2 
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Figure   3.8 :  IR Spectrum of PR2 
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Figure  3.9 :  1HNMR spectrum of  PR2 in CF3COOD 
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          Fig  3.10  : Expansion of the proton signals  of PR2 in the aromatic region 
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3.4    PR3:  N-methylouregidione 11   
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PR3 was obtained as fluorescence bright yellow amorphous solid decomposed at 199oC. 
PR3 showed an orange spot when sprayed with Dragendorff’s reagent meaning that it is 
an alkaloid. The characteristic of an oxoaporphine is showed by the deep red color when 
mixed with acid medium. 
The UV spectrum of PR3 showed absorption bands at λ max 212, 242, 275, 306, and 416 
nm indicating a highly conjugated unsaturated oxoaporphine structure. The mass 
spectrum exhibited a molecular ion peak at m/z 352.0985 [M+H] +   corresponding to the 
molecular formula of C20H17NO5. (Figure 3.11) 
The peak at m/z 337 [M-CH3]+   corresponded to the loss of methyl group attached to the 
nitrogen atom at position 7. This confirmed the existence of N-methyl group in 
compound PR3. (Figure 3.11) 
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Its IR spectrum revealed a broad absorption peak at 1712 cm-1 which corresponds to the 
presence of two carbonyl functional groups in ring B (Figure 3.12). 
The 1H-NMR (400 MHz) spectrum in CDCl3 (Figure 3.13) displayed three methoxyl 
signals at δ 4.18, 4.09 and 4.01 which correspond to methoxyl groups at C-3, C-2 and C-
1, respectively. An N-methyl group resonates at δ 3.45 (Figure 3.14).  
The presence of five aromatic protons found at δ 7.62 ( J= 8.8 Hz) as a triplet which 
belongs to H-9. The signal at δ 7.56 (J = 6.8 Hz)  as a triplet assigned for H-10 whereas 
the peak at δ7.96 appeared as a doublet with J = 8.0 Hz belongs to H-8. The H-11 signal 
appeared at very lower field which is at  δ 9.40 as a doublet with J =  8.8 Hz. This gave 
an indication that ring D is unsubstituted . The proton signal at C-7 appeared at δ 7.88 as 
one proton singlet. The proton assignments of PR3 are summarized in Table 3.3. 
The spectroscopic data obtained were in agreement with that of the previous literature 
[131]  and PR3 was established as N-methylouregidione which was isolated from 
Pseuduvaria setosa and Pseuduvaria macrophylla. 
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 Table 3.3 : 1H NMR data of PR3 (400 MHz) in CDCl3 
 Position                 1H, δ, (J, Hz) 
 
1   
 
1a   
 
1b 
 
2 
 
3 
 
3a 
 
4 
 
5 
 
6a 
 
7 
 
7a 
 
8 
 
9 
 
10 
 
11  
 
C1-OCH3 
 
C2-OCH3 
 
C3-OCH3 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
7.88, s, 1H 
 
- 
 
7.96, d, 8.0 , 1H 
 
7.62, t, 8.8 , 1H 
 
7.56, t, 6.8 , 1H 
 
9.40,d, 8.8 Hz, 1H 
 
4.18, s, 3H 
 
4.09, s, 3H 
 
4.01, s, 3H 
 
       N-CH3 3.45, s, 3H 
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Figure 3.11: A) Mass spectra and B) UV spectra of PR3 
A) 
B) 
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Figure  3.12  : IR Spectrum of PR3 
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                                         Figure  3.13   : 1H NMR  spectrum of PR3 
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                 Figure 3.14: Expansion of 1H NMR in the aromatic region (PR3) 
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3.5     PR4  : Pseuduvarine A 36 
  
                                       
NH
O
OH3CO
H3CO
N
1
2
3
43a
5
6a
7
7a
8
9
10
11
1a
1b
11a
Hb Ha
 
                                                             36 
 
PR4 was isolated as an orange amorphous solid and showed a positive reaction to 
Dragendorff’s test meaning that it is an alkaloid which contains nitrogen atom. It did not 
dissolve well in deuterated chloroform but it was highly soluble in methanol.  
An aporphine skeleton was suggested by its UV spectrum showing the λmax at   216, 261, 
323 and 425 nm indicating a highly conjugated system.  
The mass spectrum of PR4 showed a pseudomolecular ion peak at m/z 323.0764 [M+H] 
+
 suggesting a molecular formula C18H14N2O4  (Figure 3.15). The IR absorptions showed 
the characteristic for carbonyl function group at 1687 and 1614 cm-1 and NH2 group at 
3434 cm-1 (Figure 3.16). 
The 1H-NMR (700 MHz) spectrum measured in deuterated dimethylsulphoxide (DMSO 
d6) (Figure 3.17) showed signals at δ 3.98 and δ 4.07 corresponding to two methoxyl 
groups at position  C-1 and C-2.  The proton H-11 appeared as a doublet at lower field 
which is at δ 9.29 ( J = 8.0 Hz) and the proton H-8 resonated as doublet at δ 7.96 
(J=8.0Hz). 
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The proton resonated at δ 7.83 belongs to H-7 and appeared as a singlet. The signal 
appeared as a multiplet between δ 7.53 to δ 7.56 belonging to the protons positioned at 
C-9 and C-10 (Figure 3.18). This means that the ring D in the aporphine skeleton is 
unsubstituted .   
The peak appeared at δ 9.35 as a broad singlet was assigned to N-Hb group and the 
signals resonated at δ 11.90 belongs to N-Ha group and the broad singlet peak at δ 12.60 
was assigned to  N6-H
 
group. N-Ha and N6-H were deshielded by the adjacent carbonyl 
group and the signals appeared at very lower field. From the 1H NMR data, compound 
PR4 was presumed to be 1,2,3-trisubstituted-4, 5-dioxoaporphine. 
The 13C NMR data (Figure 3.19) supported the 4, 5-dioxoaporphine skeleton by 
carbonyl signals at δ 177.6 and δ 156.3 which were attributable to C-4 and C-5, 
respectively. Sixteen other carbon signals were observed which consist of two methoxyl 
groups, five aromatic C-H, and nine sp2 quaternary carbons.  
The two methoxyl carbon signals appeared at δ 59.8 and 60.9 which are attached to C-2 
and C-1, respectively.  The signal resonated at δ 114.2 belongs to C-7 whereas C-8, C-9, 
C-10 and C-11 appeared at δ 128.3, 125.2, 126.3 and 125.6, respectively. The C-3 
bearing NH2 group resonated at δ 151.00. The sp2 carbons C-1a, C-1b, C-3a, C-6a, 7a 
and 11a resonated at δ 115.1, 116.0, 105.4, 128.4, 130.8 and 127.0, respectively (Figure 
3.20). The complete assignments of all protons and carbons of compound PR4 are 
illustrated in Table 3.4. 
In COSY spectrum, there are cross-peaks between H-11 and H-10, H-10 and H-9, H-9 
and H-8, and also N-Ha and N-Hb. The structure for PR4 was further established and 
confirmed by the analysis of the 2D-NMR correlation [1H-1H COSY, HSQC, HMBC, 
and 1H-15N HMBC] as shown in Figure 3.21, 3.22, 3.23, 3.24 and 3.25).  
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The presence of NH and one NH2 functional moieties was concluded from the observed 
split cross-peaks in the 1H-15N HMBC spectrum. The position of the NH moiety was 
deduced from the HMBC correlations of H-7 to N-6 and NH to C-1b and C-4. Finally, 
the substitution pattern for ring A was deduced from the HMBC correlations of NH2 to 
C-3a (δ 105.4) (Figure 3.26 and 3.27). 
 
Therefore, PR4 was established as a new aporphine alkaloid and it was elucidated as 3-
amino-1, 2-dimethoxy-4, 5-dioxoaporphine or   Pseuduvarine A 36. This is the first 
isolation of a dioxoaporphine alkaloid with an amino group at C3 in ring A. 
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Table 3.4 : 1H(700 MHz) and 13C(175 MHz) NMR data of PR4 at 300K in DMSO d6 
Position 1H, δ, (J, Hz) 13C, δ 
1 - 158.8 
1a - 115.1 
1b  - 116.0 
2 - 144.9 
3 - 150.3 
3a - 105.4 
4 - 177.6 
5 - 156.3 
6a - 128.4 
7 7.83 (1H, s) 114.2 
7a - 130.8 
8 7.96 (1H, d, 8.0) 128.3 
9 7.53 (1H, t, 8.0) 125.2 
10 7.56 (1H, t, 8.0) 126.3 
11 9.29 (1H, d, 8.0) 125.6 
11a - 127.0 
C1-OMe  4.07  (3 H, s) 60.9 
C2-OMe 3.98  (3H, s) 59.8 
N6-H         12.60  (1H, s)      -237.8a 
N-Hb 9.35  (1H, s)      -273.3a 
N-Ha 
         
       
        11.90  (1H, s)                  -273.3a 
a 
 δN  in ppm was estimated from the cross peaks in 1H-15HMBC spectra. 
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                  Figure  3.15 : A) Mass spectra and B) UV spectra of PR4 
 
A) 
B) 
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Figure 3.16 : IR Spectrum of PR4 
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             Figure  3.17  : 1HNMR spectrum  of PR4  at  700 MHz   in  DMSO d6 
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               Figure  3.18  : Expanded 1H NMR spectrum  of PR4  in DMSO d6 
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Figure   3.19  :  13 C NMR spectrum  of PR4  in DMSO D6 
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                 Figure 3.20: Expanded 13C-NMR spectrum of PR4 in DMSO d6 
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                                  Figure   3.21  :   COSY  spectrum  of PR 4 
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                                    Figure 3.22: HSQC spectrum of PR4 in DMSO d6 
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Figure  3.23   :  HMBC spectrum of  PR4 in DMSO d6 
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                    Figure   3.24   :  1H-15N HMBC   spectrum of  PR 4 in C5D5N 
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                        Figure   3.25   : Projection of 1H-15N HMBC   spectrum of  PR 4  
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Figure 3.26: Selected 2D-NMR correlation for PR4. 
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                 Figure 3.27: 1H-15 NHMBC correlation of PR4. 
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3.6    PR5 :  Pseuduvarine B  37 
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                                                                     37 
 
PR5 was obtained as orange amorphous solids that gave a positive reaction (orange spot) 
with Dragendorff’s reagent. The UV and IR spectrum of PR5 were similar to those of 
PR4. The UV spectrum exhibited absorption maxima at 214, 261, 323 and 421 nm 
indicating a highly conjugated system and the mass spectrum showed the [M+ H] + ion at 
m/z 337.0812 suggesting a pseudomolecular formula C19H16N2O4 (Figure 3.28). Its IR 
spectrum showed absorption bands of two carbonyl groups at 1684 and 1608 cm-1 
(Figure 3.29). 
The 1H NMR (700 MHz) spectrum in deuterated DMSO (Figure 3.30) showed the 
presence of two methoxyl groups at δ 3.98 and δ 4.06 and most probably positioned at 
C-1 and C-2, respectively. The proton H-11 appeared at lower field as a doublet at δ 9.28 
(J = 8.0 Hz) and the proton H-8 resonated at δ 8.09 (J = 8.0 Hz) as a doublet (Figure 
3.31).  
There is one proton singlet resonated at δ 8.17 and it probably belongs to H-7. There is 
no other singlet peak in the spectrum and it means that C-3 was substituted with NH2 
group. The 
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 two peaks appeared as triplet resonated at δ 7.56 and  δ7.60 belongs to H-9 and H-10, 
respectively in ring D. The N-methyl group appeared at δ 3.90 as a singlet. The N-Ha 
and N-Hb  groups resonated at δ 12.04 and 9.38, respectively. See Table 3.5 for  1H  
NMR and  13C  NMR spectral data. 
The 13C NMR spectrum (Figure 3.32 and 3.33) supported the 4,5- dioxoaporphine 
skeleton by the carbon signals showing at δ 177.4 and δ 156.2 which is a characteristic 
of two carbonyl groups at C-4 and C-5, respectively. The N-methyl carbon signal 
resonated at δ 30.8 and the other signals resembled PR4 with a slight different chemical 
shift.  
The structures of PR5 were further established with 2D NMR experiments (COSY, 
HSQC and HMBC) which are shown in Figure 3.34, 3.35, 3.36 and 3.37. In the COSY 
spectrum of PR5, the proton on C11 is clearly coupled to the proton on C-10, H10 
coupled to H9; H9 coupled to H8, and N-Ha proton coupled to N-Hb proton.  
The existence of one N-Ha and one N-Hb functional moieties was concluded from the 
observed split cross-peaks in the 1H-15N HMBC spectrum (Figure 3.38). Further analysis 
of the 2D NMR data confirmed the methyl position at N-6 from the HMBC correlations 
of N6-CH3 to C-6a and C-5 (Figure 3.39 and 3.40). 
 
Based on these spectral data, it is concluded that PR5 is a new aporphine alkaloid and 
identified as N-methyl-3-amino-1,2-dimethoxy-4,5-dioxoaporphine or   Pseuduvarine B  
37. 
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Table 3.5: 1H(700 MHz) and 13C(175 MHz) NMR  data of PR5 at 300K in DMSO d6  
Position 1H, δ, (, Hz) 13C, δ 
1 - 158.7 
1a - 115.4 
1b  - 116.6 
2 - 144.6 
3 - 149.1 
3a - 104.6 
4 - 177.4 
5 - 156.2 
6a - 129.9 
7 8.17, s, 1H 114.8 
7a  130.9 
8 8.09, d, 8.0, 1H  129.0 
9 7.56, t, 8.0, 1H 125.2 
10 7.60, t, 8.0, 1H 126.7 
11 9.28, d, 8.0, 1H 125.5 
11a - 126.9 
C1-OMe 3.98, s, 3H 60.9 
C2-OMe 4.06, s, 3H 59.8 
N-Ha 12.04, s, 1H                   -242.0a 
N-Hb 
 
N6-Me 
9.38, s, 1H  
 
3.90, s, 3H  
                  -272.0a 
 
                    30.8 
 a 
 δN  in ppm was estimated from the cross peaks in 1H-15HMBC spectra. 
 
  
85
 
 
 
 
 
 
Figure 3.28 : A) Mass spectra and B) UV spectra of PR 5 
 
A) 
   B) 
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Figure  3.29  : IR Spectrum of  PR5 
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                               Figure 3.30: 1H NMR spectrum of PR5 in DMSO d6 
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              Figure 3.31: Expanded  1H NMR spectrum of PR5 in DMSO d6 
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                              Figure 3.32: 13C-NMR spectrum of PR5 in DMSO d6 
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                      Figure 3.33:  Expanded 13C-NMR spectrum of PR5 in DMSO d6 
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Figure   3.34  :  COSY  spectrum  of  PR5 in DMSO d6 
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Figure  3.35 :  HSQC  spectrum  of PR 5 in DMSO d6 
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                          Figure 3.36: HMBC spectrum of PR6 in DMSO d6 
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Figure 3.37: Expanded HMBC spectrum of PR6 in DMSO d6 
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                       Figure  3.38  :  1H- 15N  HMBC  spectrum  of PR 5   in DMSO d6 
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                       Figure  3.39  : Projection of  1H- 15N  HMBC  spectrum  of PR 5    
 
          
 
                             Figure  3.40 : 1H- 15N HMBC correlation of PR5 
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3.7  PR6  : Pseuduvarine C 38 
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                                                              38  
 
PR6 was obtained as amorphous solid. The UV of PR6 showed the maximum 
absorptions at λ max 214, 251 323 and 424 nm indicating a highly conjugated molecule. 
The mass spectrum of PR6 (Figure 3.41) revealed the [M+H] + peak at m/z 324.0679 
corresponding to the molecular formula of C18H13NO5 . The fragment ion peaks at m/z 
214 and m/z 196 showed the lost of one hydroxyl (OH). 
Its IR spectrum showed the absorption peak at 3366 cm-1 assigned for OH functional 
group and NH group at 3583 cm-1. The absorption peak at 1662 cm-1 was due to the 
carbonyl groups in the molecule (Figure 3.42) 
The 1H-NMR in CDCl3 (400 MHz) (Figure 3.43) of PR6 showed the presence of two 
methoxyl singlets at δ 4.02 and δ 4.13 which positioned at C-1 and C-2, respectively. 
There are five CH aromatic peaks in the spectrum indicating that the ring D was 
unsubstituted. The H-7 proton appeared at δ 7.70 as a singlet.  
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The peak at δ 9.36 was assigned for H-11 and appeared as a doublet with J = 9.2 Hz 
whereas the H-8 peaks was observed at δ 7.86 as a doublet with J = 7.8Hz. The H-9 and 
H-10 were resonated at δ 7.48 and 7.55, respectively and appeared as a triplet with J = 
6.8 Hz. The OH and NH peaks were observed at δ 5.26 and δ 11.70, respectively as 
broad peak. 
The 13C-NMR (Figure 3.44) spectrum showed eighteen carbon signals consist of two 
methoxyl groups, five sp2 methine, nine sp2 quaternary carbons and two carbonyl 
groups. The two methoxyl peaks appeared at δ 60.60 and δ 61.1 which attached to C-1 
and C-2 respectively. The C-7 peak resonated at δ 115.4 whereas C-10, C-9, C-11 and 
C-8 appeared at δ 125.6, 126.4, 126.9 and 128.33, respectively.  
The two carbonyl groups resonated at δ 160.1 and δ 170.2 belong to C-5 and C-4, 
respectively whereas the C-3 bearing OH group resonated at 178.5. The C-1 and C-2 
bearing the methoxyl group appeared at δ 145.0 and δ 157.5, respectively. The rest of the 
quaternary carbons peaks are tabulated in Table 3.4.  
In COSY spectrum of PR6, there are correlation between H-8 with H-9; H-9 with H-10 
and H-8; H-10 with H-9 and H-11; and H-11 with H-10 (Figure 3.45). The other 2D 
NMR spectrum could not be carried out due to insufficient amount of PR6. 
Based on the spectral data, it is concluded that compound PR6 is a new aporphine 
alkaloid identified as 3-hydroxy, 1, 2-dimethoxy, 4,5-dioxoaporphine or Pseuduvarine C 
38. 
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Table 3.6: 1H and 13C NMR Spectral data of PR6 in CDCI3 (400 and 100 MHz) 
POSITION 1H,  δ ,  (J, Hz) 13C, δ 
1 - 145.0 
1a - 116.5 
1b - 121.0 
2 - 157.5 
3 - 178.5 
3a - 115.5 
4 - 170.2 
5 - 160.1 
6a - 132.0 
7 7.84,s 115.4 
7a - 132.1 
8 7.86, d, 7.8 128.3 
9 7.48, t, 6.8 126.4 
10 7.55, t, 6.8 125.6 
11 9.36, d, 9.2 126.9 
11a - 133.0 
OH 5.26,b - 
NH 11.7,b - 
C1-OCH3 
C2-OCH3                                                    
4.02,s 
4.13
60.6 
61.1 
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Figure 3.41 : A) Mass spectra and B) UV spectra of PR6 
 
A) 
B) 
  
101 
 
 
 
Figure  3.42  : IR Spectrum of  PR6 
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Figure  3.43  :  1H NMR  spectrum  of  PR6 
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Figure  3.37  :  13 C NMR spectrum  of  PR6 
 
 
 
 
 
 
 
 
 
 
 
 
                               
 
                              Figure 3.44: 13 C NMR spectrum of PR6 
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Figure   3.45    :  COSY  spectrum  of  PR6 
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3.8   PR7 :  Pseuduvarin 39 
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                                                               39 
 
PR7 was isolated as orange amorphous in very little amount that overlapped with PR4. 
The retention time of PR7 was so close to that of PR4, 5.390 min and 5.490 min, 
respectively (Figure 3.46). 
 The UV spectrum of PR7 showed absorption bands at 216, 264 and 424 nm indicating a 
highly conjugated bond (Figure 3.47). Its IR spectrum displayed broad hydroxyl 
absorption at 3366.94 cm-1 and a carbonyl band at 1667.56 cm-1 (Figure 3.48). 
The structural elucidation of PR7 was solely based on the mass spectroscopic data. From 
the mass spectroscopic chromatogram, PR7 had nearly the same retention time as PR4.  
It was first detected using the LCMS/MS in a negative ion mode. At first, it was thought 
that the unknown compound was an alkaloid, but further test with Dragendorff’s reagent 
gave a negative result.  
The mass spectrum of PR7 showed a pseudomolecular ion peak [M+ H]+ at m/z 
323.0807 suggesting a possible molecular formula of C15H14O8. The base peak appeared 
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 at m/z 307 indicating the loss of one methyl group which was followed by another 
fragment ion at m/z 292 indicating another loss of methyl group. The subsequent product 
ions at m/z 264, 236, 208 and 180 indicated the lost of four carbonyl groups (Figure 
3.49).  The fragmentation pattern of PR7 is shown as below:  
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Based on the fragmentation pattern of PR7, we deduce that PR7 is 1-Hydroxy-2,3,9,-
trimethoxy-9-methyl-5H-benzo [7] annulene-5,6,7,8(9H)-tetraone  or Pseuduvarin 39.  
This is a new compound which has never been isolated from any plant species.  
 
 
 
Figure 3.46: HPLC chromatograms of PR4 and PR7 in MeOH extract. 
 
 
 
 
 
PR4 PR7 
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Figure 3.47 : A) Mass spectrum and B) UV spectrum of PR7 
 
A) 
B) 
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                                  Figure 3.48: IR spectrum of PR7 
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Figure 3.49: Total ion mass spectrum of PR7 in negative ion mode 
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3.9 GCMS Analysis of the Hexane Extract 
The hexane extract of Pseuduvaria rugosa was analysed by GC/MS analysis. The 
structures of the compounds were identified based on the percentage similarity values 
and the fragmentation pattern of the mass spectra in comparison with those of reference 
standard compounds in the computer database using NIST standard library reference 
(NIST – National Institute of Standards and Technology-Chemistry) and also by 
matching data from those reported in the previous literature. The relative content of each 
component was determined by peak area normalization. About 50 peaks were detected 
and 41 compounds with more than 80% similarities were observed.  
The five major components identified in the hexane extract of Pseuduvaria rugosa were 
elimicin 24, isoelimicin 40 , 1,2,3,4-tetramethoxy-5-(2-propenyl)benzene 41 , 3 -
Hydroxyl -1 -propenyl-2 methoxyphenol 42 , stigmasterol 43 and gamma sitosterol 44. 
A representative chromatogram of the hexane extract is shown in Figure 3.50. 
The largest peak, which eluted at retention time 24.78 minute, was identified as 
isoelemicin 40 with a molecular weight of 208. The second larger peak eluted at 
retention time 22.57 minute was identified as elemicin 24.    
                   
                              
OCH3
OCH3
OCH3
 
                                                       40 
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The following third prominent peak  at retention time 23.49 minute with molecular 
weight of 238 was assigned for 1,2,3,4-tetramethoxy-5-(2-propenyl)benzene 41.  
 
                                      
OCH3
OCH3
OCH3
H3CO
 
                                                             41 
                                                                                                           
The fourth peak at retention time 26.733 was matched to a phenolic compound, 
identified as 3 -Hydroxyl -1 -propenyl-2 methoxyphenol 42 with a molecular weight of 
180. 
 
                                         
OHCH3
O
HO
 
                                                                    42 
The last two major peaks at longer retention time, 65.74 and 70.82 minute with 
molecular weights of 412 and 414, respectively, belong to stigmasterol 43 and gamma-
sitosterol 44. 
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HO
 
                                                                   43   
 
 
                            
HO
 
                                                                     44 
Other minor components were some monoterpenes, sesquiterpenes , diterpenes and ether 
that include spathulenol 29, caryophyllene oxide 30 , selina-6-en-4-ol, asarone, palmitic 
acid and ethyl 9-octadecenoate .  
The mass fragment ions of target compounds compared to that of the standard 
compounds in the NIST library with more than 80% similarities are shown in Table 3.7. 
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Table 3.7: GCMS spectral data of the compounds in the hexane extract of P.rugosa  
Peaks RT(min) Area 
% 
SI MW  Molecular 
formula 
1.   Elemicin 24 22.558 5.59 93 208 C12H16O3 
2.  1,2,3,4-tetramethoxy-
5-(2-propenyl)benzene 41 
23.498 4.66 87 238 C13H18O4 
4.   Selina-6-en-4-ol 23.917 1.26 83 222 C15H26O 
5.   Spathulenol  29 24.258 1.92 85 220 C15H24O 
6.    Isoelemicin  40 24.783 7.05 92 208 C12H16O3 
7.   Caryophyllene oxide30 25.227 1.05 81 220 C15H24O 
8.   Asarone 25.367 1.28 89 208 C12H16O3 
9.  3-Hydroxy-1-propenyl 
     - 2methoxyphenol 42 
26.733 3.16 90 180 C10H12O3 
10. Palmitic acid 31.642 1.11 93 284 C18H36O2 
11. Ethyl 9-octadecenoate  
       
34.817 1.53 85 310 C20H38O2 
12. Stigmasterol  43 65.741 4.51 88 412 C19H36O2 
13. Gamma -Sitosterol 44 70.083 6.25 95 414 C29H50O 
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Figure 3.43:  GC/MS Chromatogram of Hexane Extract. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.50: GCMS Chromatogram of hexane extract  
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3.10  BIOACTIVITY  EVALUATION 
The hexane, dichloromethane and methanol extracts of Pseuduvaria rugosa and isolated 
compounds PR 36 and PR 37 were tested for their in vitro antioxidant and cytotoxic 
activity. Other isolated compounds were not enough for antioxidant and cytotoxic 
activity tests. The total phenolic content of the crude extracts were also determined with 
gallic acid as the standard.  
3.10.1 Antioxidant Activity by DPPH method 
The antioxidant activity of the crude extracts of hexane, dichloromethane and methanol 
of Pseuduvaria rugosa were preliminary screened in vitro using DPPH free radical 
scavenging assay at 100 µg/ml. The results are shown in Table 3.8. 
Results showed that the hexane extract exhibited very poor scavenging activity with 
3.86% of inhibition when compared with standard ascorbic acid. The dichloromethane 
extract showed lower scavenging activity (19.32% inhibition) and the methanol extract 
showed moderate scavenging activity (34.78 % of inhibition). In general, more than 50% 
inhibition is considered active. 
Overall, all the crude extracts did not show any significant radical scavenging activity 
compared to ascorbic acid as a standard. There was no correlation between antioxidant 
activity and total phenolic content of the crude extracts. The total phenolic content 
revealed that the crude extracts did not contain phenolic compounds as the major 
component. 
Since the results in the preliminary screening did not show any significant activity, the 
analysis on the antioxidant activity of the isolated compounds was not carried out due to 
insufficient samples. From the preliminary screening of antioxidant activity, it can be 
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concluded that the crude extracts from the stem bark of Pseuduvaria rugosa may not be 
a suitable potential sources for natural antioxidant. 
 
Table 3.8. Antioxidant activity and total phenolic content of crude extracts. 
Crude extract % inhibition* Total phenolic content 
(ugGAE/1mg ) 
Hexane 
 
3.86 119.21 
Dichloromethane 
 
19.32                    195.66 
Methanol 
 
34.78                    114.10 
Ascorbic acid   
(standard) 
 
84.22 _ 
*percentage of DPPH inhibition of extract at 100 µg/mL 
 
3.10.2  In vitro Cytotoxicity test 
The crude extracts were initially evaluated for their cytotoxic activities on seven cancer 
cell lines. The results of the cytotoxic activity of hexane, dichloromethane and methanol 
crude extracts are summarized in Table 3. The results showed that the hexane, 
dichloromethane and methanol extracts of Pseuduvaria rugosa exhibited significant 
activity against all the seven cancer lines at 100 µg/ml. The hexane and dichloromethane 
extract exhibited potent cytotoxicity against breast (MCF7), colon (HT-29) and pancreas 
cell lines (PxPC3) with more than 90% of cell death. 
 
 
  
122 
 
Table 3.9: Cytotoxic activity of crude extracts of Pseuduvaria rugosa 
 Hexane Dichloromethane Methanol 
Cancer cell    lines  Cell Death (%) 
 
Breast (MCF7) 
 
100 
 
97.7 
 
91.5 
 
Breast (MDA-MB-231) 
 
68.6 
 
87.5 
 
63.6 
 
Colon (HT-29) 
 
93.7 
 
96.0 
 
57.3 
 
Lung (A549) 
 
54.2 
 
76.7 
 
9.30 
 
Pancreas (PxPC-3) 
 
93.2 
 
94.6 
 
94.8 
 
Prostate (DU145) 
 
60.3 
 
79.2 
 
45.2 
 
Liver (HepG-2) 
 
82.7 
 
87.7 
 
13.3 
Note:MCF7-Estrogen receptor positive,MD-MB-231-estrogen receptor negative 
 
The cytotoxicity of the new two new alkaloid compounds, PR36 and PR37 were tested 
against breast cells  (MCF7 ), liver cells (HepG2) and human lung cells (HL-60) using 
the MTT assay.  
Results showed that PR36 and PR37 showed significant and potent cytotoxicity and 
selectivity towards the tested cells, with Pseuduvarine A  36  being the most toxic 
against breast cells (MC7) at IC50 value of  0.9 µM and Pseuduvarine 37  being the most 
toxic and selective on human promyelocytic leukemia (HL-60) cell lines. 
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Table 3.10 : Cytotoxic activity of PR36 and PR37 at IC50 
COMPOUNDS MCF7  HEPG2  HL-60  
 
*IC50 (uM)  
Compound PR36 0.90 21.7  >50  
Compound PR37 >50  15.7  12.4  
*IC 50  represents the concentration causing a 50% cytotoxic  effect 
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                                                   CHAPTER 4 
CONCLUSION 
 
The phytochemical investigation of the stem bark of Pseuduvaria rugosa have led to the 
isolation of seven compounds, six of them were aporphine alkaloids of which  three 
were known compounds: Liriodenine 1, ouregidione 5 and N-methylouregidione 11 
while the other three compounds were new aporphine alkaloids, pseuduvarine A 36, 
pseuduvarine B 37 and  pseuduvarine C 38 . The seventh compound, pseuduvarin 39 is 
believed to be a new compound having benzo[7]annulene skeleton which is not fully 
identified that has not been isolated before from any plant species.  
The GC/MS analysis of the hexane extract revealed some fatty acids and terpenoids, of 
which the major compounds were isoelimicin 40, 1,2,3,4-tetramethoxy-5-(2-
propenyl)benzene 41 (phenolic ether) and 3-Hydroxyl-1-propenyl-2 methoxyphenol   
42. 
The other compounds are elimicin 24,  spathulenol 29 and caryophyllene oxide 30  
which were previously identified  from leaf essential oils of Pseuduvaria froggattii and 
Pseuduvaria mulgraveana. The sterol compounds found in Pseuduvarisa rugosa are 
stigmasterol 43 and gamma-sitosterol 44. 
In this study, the antioxidant and cytotoxic activities from the bark of Pseuduvaria 
rugosa were evaluated. The results of the study revealed that the crude extracts of 
Pseuduvaria rugosa demonstrated strong cytotoxic activity but moderate antioxidant 
activity.  
Preliminary screening of the crude extracts of Pseuduvaria rugosa on the antioxidant 
activity using DPPH method revealed low to moderate radical scavenging activities in 
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all hexane, dicholoromethane and methanol crude extracts, thus , it can be concluded 
that the plant is not a potential source for natural antioxidant.  
In the preliminary screening to determine the cytotoxicity of the crude extracts against 
seven cancer cell lines, all the crude extracts (hexane, dichloromethane and methanol) 
showed significant cytotoxic activity against the seven cancer cell lines with more than 
80% of cell death.  
The hexane and dichloromethane extracts of Pseuduvaria rugosa showed potent 
cytotoxic activity against breast, lung and pancreas cell lines. Further test with the 
isolated compounds, ouregidione 5, N-methylouregidione 11, pseuduvarine C 38 and 
pseuduvarine 39 showed moderate activity or no activity at all in the cytotoxic bioassay 
test. It could be the synergetic effects from other compounds in the crude extracts that 
demonstrated the significant cytotoxic activities.  
However, the two new alkaloids with the amino group at C-3,  pseuduvarine A 36 and 
pseuduvarine B 37 isolated from the methanol extract showed significant activity and 
selectivity in the cytotoxic test against three cancer cell lines namely human breast 
adenocarcinoma (MCF7), human liver carcinoma cells (HepG2) and human 
promyelocyctic leukemia cells (HL-60). This justified the claims that this plant may 
possess anticancer properties.  
Some of the limitations in this study include insufficient amount of the isolated 
compounds which were yielded in very small quantities that were not enough for further 
structure elucidations and further bioactivity tests. In the case of pseuduvarin C 38 and  
pseuduvarin 39, the yield for the pure compound was so little to be fully analysed by 
NMR and 2D NMR. Most of the time, most of the compounds overlapped with one 
another. 
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The information and data from this study will enable other scientists and researchers to 
compare data from other Pseuduvaria species which were quite limited at this time and 
hopefully with further investigations,  the new compounds PR36 and PR37 can be 
developed to be a potential candidate for anticancer agent. 
It is proposed that further study  to be carried out to isolate pseuduvarin C 38 and  
pseuduvarin 39 in a larger amount in order to confirm the structure of the compounds by 
means of NMR and 2D NMR. 
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CHAPTER FIVE 
  EXPERIMENTAL 
 
5.1 General Experimental Procedures 
5.1.1 Solvents 
All solvents used such as hexane, dichloromethane and methanol for soxhlet extraction, 
column separation and fractionation are of analytical grade (AR). Solvents such as 
acetonitrile (ACN) and methanol were of HPLC grade for HPLC analysis. 
5.2   Instrumentation and Spectroscopic Methods 
5.2.1 Optical rotation 
Optical rotation was measured on a JASCO DIP-1000 polarimeter with methanol and 
chloroform as solvent. 
5.2.2 UV Spectra 
Ultraviolet (UV) spectra were recorded on LCMS- IT-TOF equipped with a PDA 
detector set at the range of 200-400nm.  
5.2.3 IR Spectra 
The infrared (IR) spectra were recorded on Perkin Elmer FT-IR Spectrometer Spectrum 
RX1 using chloroform as the solvent. 
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5.2.4   NMR Spectra 
NMR spectra and data analysis were obtained using JEOL FT NMR,  JEOL ECA400 
FT NMR and 700 MHz with deuterated chloroform (CDCI3), deuterated methanol 
(CD3OD) and deuterated DMSO used as solvents. Chemical shifts were reported in ppm 
and coupling constants were measured in Hertz (Hz). 
5.2.5   Mass Spectra 
Mass  spectra were recorded on LCMS/MS Shimadzu IT-TOF with Waters  X- Bridge 
RP C-18 column ( 2.1 mm id x 50 mm, particle size 2.5 um) using HPLC grade 
acetonitrile in 0.1% Formic Acid (Solvent B) and deionized water in 0.1% Formic Acid 
(Solvent A). 
5.2.6 GCMS 
The analysis of the hexane extract was performed on JEOL JMS 600H Aglest 68, 
equipped with 30m x 0.32 mm HP-5 column, stationary phase coating 0.50 um. The 
column temperature was kept at 250oC  for 2 min with increased at the rate  of 5oC per 
min up to 250o C. Injector temperature 250oC, split ratio 1;35, the carrier gas ( Helium) 
flow rate 1.8 ml/min. 
5.3 Chromatography Separation 
5.3.1 Thin layer Chromatography (TLC) 
TLC was carried out using aluminium supported silica gel 60 F254 TLC sheets to detect 
the separation of the compounds. The spots were visualized under UV light at 
wavelength 254 nm and 366 nm using the CAMAG TLC UV Visualizer. 
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5.3.2 Preparative Thin Layer Chromatography (PTLC) 
PTLC silica gel 60 F254 (Merck) glass plates (20x20cm) were used for the compound 
separations. 
5.3.3 Column Chromatography (CC) 
Separation and fractionation of the crude extracts were conducted using 
chromatographic columns packed with Silica Gel 60F (230-400 mesh) with ratio 30:1 
for the crude samples. 
5.3.4 High Performance Liquid Chromatography (HPLC) 
HPLC analysis, fractionation and purification were performed by preparative reverse 
phase HPLC using Waters Nova-Pak C18 column (25 x 100 mm, particle size 6 um) 
using acetonitrile and water with 0.1% formic acid as the eluants. HPLC chromatograms 
were monitored at 250-450 nm. HPLC analysis of the crude fractions previously 
partitioned using column chromatography was conducted on 150 x 3.9 mm i.d Nova 
Pak C18 RP (Waters) column, using solvent A (Acetonitrile in 0.1% FA) and solvent B 
(Water in 0.1% FA). A program of isocratic elution with 100% A from 0 to 15 min, a 
linear gradient to 100% B from 15 to 45 min, at a flow rate of 0.8 ml/min was used.  
5.4 Detector Reagent 
Mayer’s and Dragendorrf’s reagents were used to detect the presence of alkaloids and 
heterocyclic nitrogen compounds. 
a. Mayer’s reagent (Potassium mercury  iodide) 
b. Dragendorff’s reagent (purchased from Sigma) 
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5.5 Plant Material 
The stem bark of Pseuduvaria Rugosa  (KL 5186) was collected at Hutan Simpan 
Hijau, Lenggong, Perak and identified by L.E. Teo  &  J.C. Tetu  (Herbarium group of  
Phytolab)  from the Department of Chemistry, University of Malaya. It was tagged and 
kept in the herbarium until analysis 
5.5.1   Sample Extraction, Fractionation and Isolation 
The extraction of crude extracts was carried out by Soxhlet extraction using the Soxhlet 
extractor.  The advantage of this method is that large amount of compounds can be 
extracted with smaller amount of solvents, and also the solubility of the active principle 
and gradient concentration and polarity increases with the increasing of temperature that 
will result an enhanced mass transfer of active principle from solid material to the 
solvent [146]. By using this method, the sample is repeatedly extracted by every cycle 
of fresh solvent. 
About 500g of dried ground bark of Pseuduvaria Rugosa was subjected to Soxhlet 
extraction for 16 hours using 2.5 L of hexane to remove fatty acids and lipid matters 
(Scheme 5.1). The defatted plant sample was filtered and dried, and moistened with 
15% ammonia (NH4OH) and left to soak overnight. Ammonia helps to free the alkaloid 
compounds from their salt forms [147]. Then the sample was exhaustively extracted 
with dicloromethane solvent by Soxhlet extractor for about 16 hours at a controlled 
temperature. (Overheating of the sample can decompose the compounds) 
The crude dicloromethane extract (10.49g) obtained as dark green extract was subjected 
to acid- base extraction to yield crude alkaloid. The dichloromethane extract was 
concentrated to 500 ml using the rotary evaporator. The concentrated sample was 
further re-extracted with 5% HCL and partitioned using liquid-liquid extraction until 
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Mayer’s test is negative. The aqueous base was basified to pH 11 with ammonia and re-
extracted with dichoromethane.  
The organic layer was collected, washed with distilled H20 and sodium chloride 
solution, and excess water was removed by sodium sulfate anhydrous, and filtered. 
Finally, the dichloromethane extract was evaporated to yield crude alkaloids (1.58 g) 
(0.32%). 
The hexane extract (27.45g) was subjected to GCMS analysis to identify the chemical 
constituents. The methanol extract (21.95g) was further fractionated with preparative 
reverse-phase HPLC.  A gradient of 30% to 100% (v/v) acetonitrile in water was 
applied with a flow rate of 12 ml/min over 60 minutes.  From the methanol extract, 2 
peaks were detected and the fractions (27-30) and (42-45) from the 2 peaks were later 
isolated and evaporated. 
Purified compounds PR4; Pseuduvarine A 36 (3.1 mg) was obtained from fraction 29, 
compound PR5; Pseuduvarine B 37 (2.9 mg) was obtained from fraction 44 , PR6 
Pseuduvarine C 38 was afforded from fraction 28, and PR 6; Pseuduvarin 39 was 
afforded from fraction 30 of the methanol extract using the HPLC (Figure 5.1).  
Purified compounds PR1; Liriodenine 1, PR2; Ouregidione 5 and PR3; N-methyl 
ouregidione 11 were obtained from fraction, 17-18, 28-39 and 40-46 of the alkaloid 
extract, respectively, using the column chromatography. All purified compounds are 
summarized in Table 5.8 
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5.5.2   Isolation of the crude alkaloids  
The crude alkaloid extract (1.5g) was then subjected to chromatographic separation over 
a column of silica gel in ethyl acetate and eluted with increasing amount of methanol. 
Each fraction of about 100ml was collected in a clean tube.  
The homogeneity of the fractions and the Rf values were then monitored by TLC and 
visualized under the UV light at wavelength 254 nm and 366 nm (Figure 5.2). Fractions 
with similar TLC profiles and Rf values were then combined for further 
chromatographic analysis. The spots on TLC sheets were sprayed with Drangendorff’s 
reagent to detect the presence of alkaloids. 
A total of 85 fractions were collected. Fraction 1-18 (10.8 mg), fraction 19-27 (9.8 mg), 
fraction 28-39 (33.6 mg), fraction 40-46 (14.4 mg), fraction 47-55 (79.9 mg), fraction 
56-61 (94 mg ), fraction 62-66 (42.4 mg), fraction 67-70 (18.9 mg), fraction 71-79 (17.9 
mg) and fraction 80-85 ( 17.7 mg). 
5.6 Total Phenolic Contents 
Total phenolic content of the bark of Pseuduvaria rugosa was determined according to 
the Folin-Ciolcalteau method  by using gallic acid as standard C [148]. 150 ul of sample 
was added to 750 ul of Folin-Ciolcalteau reagent and 600 ul of sodium carbonate in a 
tube. Then the tubes were incubated at 50oC for 10 min. The absorbance is read was 
read at 760 nm against a blank methanol.  The results were expressed as ug of total 
phenolics in mg of extract as GAE. 
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5.7 Antioxidant and Cytotoxic Activity Test 
5.7.1 DPPH method  
DPPH is a simple and widely used method to preliminary evaluate the antioxidant 
activity of a compound or plant extracts [149]. This method measure radical scavenging 
activity of the antioxidants against free radicals (DPPH) 1, 1-diphenyl -2-picrylhydrazyl 
radical.  
The principle of the method: DPPH is a stable free radical that was originally purple in 
color (when absorbed at 517 nm). When the radical is scavenged by the process of 
hydrogen radical or electron donation, DPPH change to yellow color due to the 
formation of diphenylpicrylhydrazine [150]. 
 In this study, the determination of DPPH radical scavenging assay was carried out by 
method Blois (1958) with some modifications [151]. DPPH, ascorbic acid and methanol 
were obtained from Sigma Chemical, Malaysia. 
In a 96 well plates, 20 uL of sample from sample concentration (200ug/ml) was added 
to 50 uL of DPPH solution (0.02%) and 130 uL of methanol to reach the total volume of 
200 uL. For the control, 20 uL of Ascorbic acid was added to 50 uL of DPPH solution 
(0.02%) and 130 uL of methanol.  Ascorbic acid is used as the reference standard and 
blank methanol was used as the negative control. The mixtures were shaken and the 96 
well plate was incubated in the dark for 30 minute at room temperature. Then the 
absorbance was measured at 517 nm using UV Spectrophotometer. The percentage 
inhibition of the sample was calculated following the formula : 
 
% of inhibition  =     Absorbance (control)- Absorbance ( sample ) x 100 
                                                       Absorbance (control) 
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5.7.2 In vitro cytotoxicity test 
5.7.2.1 Materials  
Crude extracts of hexane, dichloromethane and methanol (200ug/mL) were tested 
against seven cancer cell lines obtained from American Type Culture Collection  
(ATCC) (Manassas, VA, USA) investigate the cytotoxic activity.  
Dulbecco’s modified Eagle’s medium (DMEM), 100 mM non-essential amino acids, 
phosphate buffer solution (pH 7.2), 50 µg/mL gentamycin and 2.5 µg/mL amphotericin 
B were purchased from Invitrogen Corporation (Carlsbad, CA, USA).  
200 mM L-glutamine, foetal bovine serum, 0.25% trypsin-EDTA, dimethyl sulphoxide 
(DMSO), cisplatin and vinblastine sulphate were purchased from Sigma–Aldrich (St. 
Louis, MO, USA). MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulphophenyl)-2H-tetrazolium, inner salt]  assay kit (CellTiter 96® AQueous One 
Solution) was obtained from Promega (Madison, WI, USA).  
5.7.2.2 Method 
(MTS Assay) 
The cytotoxicity of the compounds was evaluated against breast cancer cell line (MCF-
7). Cell lines were cultured in DMEM media supplemented with 2 mM L-glutamine, 
10% foetal bovine serum, 50 µg/mL gentamycin and 2.5 µg/mL amphotericin B, 
maintained in a 37 ºC humid atmosphere of 5% CO2 cell incubator. Samples and drug 
standards (cisplatin, vinblastine sulphate and doxorubicin HCl) were dissolved in 
DMSO
 
and immediately diluted with DMEM media to yield a final DMSO  
.  
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concentration of less than 0.5% v/v. Cells were plated into 96-well microplates at 
10,000 cells per well and maintained in the cell incubator for 24 hour. Then, 100 µL of 
samples were introduced in triplicates to a final concentration of 15–150 µM for pure 
compounds and 15–150 µg/mL for extract.  
Culture media were carefully refreshed with 100 µL of DMEM media, followed by 20 
µL per well of MTS reagent. Microplates were returned to the incubator for 1-2 hours 
and absorbance of the formazan product was read on a microplate reader at 490nm with 
690nm as the background wavelength (Infinite 200, Tecan, Männedorf, Swizerland). 
IC50 of samples and drug standards were determined using dose-response curves in 
Prism 5.02 software (GraphPad Software Inc., La Jolla, CA, USA). 
Cell viability and death were calculated as percentage from the absorbance readings 
following the equations: 
Cell viability (%) = A (sample)/ A (control) x 100% 
Cell death (%) = 100% - cell viability (%) 
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(MTT assay) 
HL-60, human promyelocyctic leukemia cells were maintained in RPMI-1640 medium; 
MCF7, human breast adenocarcinoma; and HepG2, human liver carcinoma cells were 
maintained in Dulbecco’s modified eagle medium (DMEM) medium. Both growth 
medium were supplemented with 10% fetal calf serum and 1% Penicillin-Streptomycin.  
The cells (5 x 103 cells/well) were cultured in Nunc disposable 96-well plates 
containing 90 µL of growth medium per well and were incubated at 37oC in a 
humidified incubator of 5% CO2. 10 µL of samples were added to the cultures at 24 
hours of incubation. After 48 hours of incubation with the samples, 15 µl of 3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) (5 mg/ml) were added 
to each of the wells.   
The cultures were incubated for another 3 h before the cells supernatant are removed.  
After the removal of the cells supernatant, 50 µL of dimethyl sulfoxide (DMSO) was 
added to each well.  The formed formazan crystal was dissolved by re-suspension by 
pipette.   
The optical density was measured using a microplate reader (Bio-Rad, USA) at 550 nm 
with reference wavelength at 700 nm. In all experiment, three replicates were used.  
Cisplatin was used as positive control (IC50: 0.87 µM for HL-60, 27.7 µM for MCF7, 
and 12.3 µM for HepG2). 
 
 
 
  
137 
 
 
            Figure 5.1: Diagram of extraction and isolation of pure compounds  
                                 from   Pseuduvaria rugosa. 
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     Figure 5.2:  TLC fractions of crude alkaloid extracts under UV light  
                          at 254 nm (top) and 366 nm (bottom) 
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                       Figure 5.3: HPLC Chromatogram of MeOH extract 
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Table 5.1: Yield of isolated compounds from the stem bark of Pseuduvaria rugosa 
Compounds  Yield (mg) Percentage yield 
Liriodenine  1 3.5  0.00070 
Ouregidione  5 3.0 0.00060 
N-methylouregidione  11 2.8 0.00056 
Pseuduvarine A  36 3.1 0.00062 
Pseuduvarine B  37 2.9 0.00058 
Pseuduvarine C  38 2.5 0.00050 
Pseuduvarin   39 0.8 0.00016 
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5.8 Physical and Spectral Data of the Isolated Compounds 
Liriodenine  1                                      :  Bright yellow needles 
Molecular formula   :  C17H9NO3 
UV λ max (MeOH)                               :  255, 276, 327,401 nm 
IR max cm-1                                           : 965, 1660 
Mass spectrum m/z                                :  276.0448, 247, 219 
1
 H NMR (CDCI3) ppm                         :  Refer Table 3.1 
13
 C NMR (CDCI3)ppm                         :  Refer Table 3.1 
 
Ouregidione  5                                       :  Orange amorphous solid 
Molecular formula                                  :  C19H15NO5 
UV λ max (MeOH)                                 :   213, 229, 488 
IR max cm-1                                             :  1733, 1667, 1455, 3436 
Mass spectrum m/z                                  :  338, 323, 321, 309 
1
 H NMR (CDCI3) ppm                           :  Refer Table 3.2 
13
 C NMR (CDCI3)ppm                         : not available 
 
N-methyl  Ouregidione  11 : Bright yellow amorphous solid 
Molecular formula                                  :  C20H17NO5 
UV λ max (MeOH)                                 :  212, 242, 275,306, 416 
IR max cm-1                                             :  1712, 1601, 1274 
Mass spectrum m/z                                  :  352, 338,323,292,276 
1
 H NMR (CDCI3) ppm                           :  Refer Table 3.3 
13
 C NMR (CDCI3)ppm                         :  Not available 
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Pseuduvarine A 36                                 : orange amorphous solid 
Molecular formula                                  :  C18H14N2O4 
UV λ max (MeOH)                                 :  216, 261, 323, 425 
IR max cm-1                                             :  1687, 1614 
Mass spectrum m/z                                  :  323, 295, 276, 214 
1
 H NMR (CDCI3) ppm                           :  Refer Table 3.3 
13
 C NMR (CDCI3)ppm                         :  Refer Table 3.3 
 
Pseuduvarine B 37                                 : orange amorphous solid 
Molecular formula                                  :  C19H16N2O4 
UV λ max (MeOH)                                 :  214, 261, 323, 421 
IR max cm-1                                             :  1684, 1608 
Mass spectrum m/z                                  :  337, 308, 275, 214 
1
 H NMR (CDCI3) ppm                           :  Refer Table 3.4 
13
 C NMR (CDCI3)ppm                         :  Refer Table 3.4 
 
Pseuduvarine C 38                                : orange amorphous solid 
Molecular formula                                  :  C18H13NO5 
UV λ max (MeOH)                                 :  214, 251, 323, 424 
IR max cm-1                                             :  3366, 3583 
Mass spectrum m/z                                  :  324, 276, 214 
1
 H NMR (CDCI3) ppm                           :  Refer Table 3.6 
13
 C NMR (CDCI3)ppm                         :  Refer Table 3.6 
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Pseuduvarine 39                               : orange amorphous solid 
Molecular formula                                  : C15H14O8 
UV λ max (MeOH)                                 :  216, 264, 424 
IR max cm-1                                             : 1667, 3366 
Mass spectrum m/z                                  : 323, 308, 262 
1
 H NMR (CDCI3) ppm                           : not available 
13
 C NMR (CDCI3)ppm                         : not available 
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